Department of Immunology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin 300060, China.
Department of Biotherapy Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin 300060, China.
Cancer Biol Med. 2020 Nov 15;17(4):923-936. doi: 10.20892/j.issn.2095-3941.2020.0338. Epub 2020 Dec 15.
Exhausted T cells are a group of dysfunctional T cells, which are present in chronic infections or tumors. The most significant characteristics of exhausted T cells are attenuated effector cytotoxicity, reduced cytokine production, and upregulation of multiple inhibitory molecular receptors (e.g., PD-1, TIM-3, and LAG-3). The intracellular metabolic changes, altered expression of transcription factors, and a unique epigenetic landscape constitute the exhaustion program. Recently, researchers have made progress in understanding exhausted T cells, with the definition and identification of exhausted T cells changing from phenotype-based to being classified at the transcriptional and epigenetic levels. Recent studies have revealed that exhausted T cells can be separated into two subgroups, namely TCF1PD-1 progenitor-like precursor exhausted cells and TCF1PD-1 terminally differentiated exhausted T cells. Moreover, the progenitor-like precursor cell population may be a subset of T cells that can respond to immunotherapy. Studies have also found that TOX initiates and dominates the development of exhausted T cells at the transcriptional and epigenetic levels. TOX also maintains T cell survival and may affect decisions regarding treatment strategies. In this review, we discuss the latest developments in T cell exhaustion in regards to definitions, subpopulations, development mechanisms, differences in diverse diseases, and treatment prospects for exhausted T cells. Furthermore, we hypothesize that the epigenetic state regulated by TOX might be the key point, which can determine the reversibility of exhaustion and the efficacy of immunotherapy.
耗竭的 T 细胞是一群功能失调的 T 细胞,存在于慢性感染或肿瘤中。耗竭 T 细胞的最显著特征是效应细胞毒性减弱、细胞因子产生减少以及多种抑制性分子受体(如 PD-1、TIM-3 和 LAG-3)上调。细胞内代谢变化、转录因子表达改变以及独特的表观遗传景观构成了耗竭程序。最近,研究人员在理解耗竭 T 细胞方面取得了进展,耗竭 T 细胞的定义和鉴定已从表型基础转变为转录和表观遗传水平的分类。最近的研究表明,耗竭 T 细胞可分为两个亚群,即 TCF1PD-1 祖细胞样前体细胞耗竭细胞和 TCF1PD-1 终末分化耗竭 T 细胞。此外,祖细胞样前体细胞群可能是对免疫治疗有反应的 T 细胞亚群之一。研究还发现,TOX 在转录和表观遗传水平上启动并主导耗竭 T 细胞的发育。TOX 还维持 T 细胞的存活,并可能影响治疗策略的决策。在这篇综述中,我们讨论了 T 细胞耗竭在定义、亚群、发育机制、不同疾病中的差异以及耗竭 T 细胞的治疗前景方面的最新进展。此外,我们假设由 TOX 调节的表观遗传状态可能是关键,它可以决定耗竭的可逆性和免疫治疗的疗效。